Antibacterial surface coatings for biomedical applications by Atefyekta, Saba
   
 
 
 
THESIS FOR THE DEGREE OF LICENTIATE OF ENGINEERING 
 
 
 
 
 
 
 
Antibacterial surface coatings for biomedical 
applications 
 
 
 
 
 
 
SABA ATEFYEKTA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Department of Chemistry and Chemical Engineering 
 
CHALMERS UNIVERSITY OF TECHNOLOGY 
 
Gothenburg, Sweden 2016 
 
 
   
I 
 
 
Antibacterial surface coatings for biomedical applications 
SABA ATEFYEKTA 
 
 
© SABA ATEFYEKTA, 2016. 
 
 
Licentiatuppsatser vid institutionen för kemi och kemiteknik 
Chalmer tekniska högskola 
Serie Nr: 2016:14 
ISSN: 1652-943X 
 
Department of Chemistry and Chemical Engineering 
Chalmers University of Technology 
SE-412 96 Gothenburg 
Sweden 
Telephone + 46 (0)31-772 1000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cover: SEM images and flourecent microscopy images of S.epidermidis formed on ELP 
substrates before and after AMP modification.for SEM images (top row), The bacteria 
were seeded on  ELP coated glass coverslips, fixated using formaldehyde and gold 
sputtered prior to imaging. For florencent microscopy images (bottom row), The 
bacteria were stained with SYTO 9 and propidium iodide. 
 
 
 
 
Chalmers Reproservice 
Gothenburg, Sweden 2016 
 
 
   
II 
 
Antibacterial surface coatings for biomedical applications 
 
SABA ATEFYEKTA 
Department of Chemistry and Chemical engineering 
CHALMERS UNIVERSITY OF TECHNOLOGY 
 
 
Abstract 
 
Over the past decades there has been a significant increase in the diversity and function of biomaterials. 
Today, medical practices utilize a large number of biomaterials in the form of medical devices and 
implants. However, one major obstacle that limits the efficiency of biomaterials is their susceptibility to 
develop infection. Biomaterials associated infection caused by adherent biofilms is usually difficult to 
hinder by means of systemic antibiotic therapy. In addition, the rapid emergence and growth of antibiotic 
resistant bacterial strains is further limiting the potency of available antibiotics used to treat infections. 
To address these limitations, different surface modifications are considered to be an effective solution 
to improve antibacterial performance of biomaterials by hindering biofilm formation.  
In this thesis, two different strategies to create surfaces with pronounced antibacterial properties have 
been developed and evaluated. In both methods, the antibacterial modification has been deposited onto 
bioactive surface coatings to further improve their future clinical performance. In the first approach, 
mesoporous titania (MPT) surface coatings were used as antibiotic carriers to investigate the effect of 
local delivery of the antibiotics Vancomycin, Gentamicin and Daptomycin on the attachment and growth 
of  S. aureus and P. aeruginosa. MPT thin films with pore diameters of 4, 6, and 7 nm were formed 
using the evaporation-induced self-assembly method. Reduced bacterial adhesion was observed on the 
antibiotic loaded surfaces. It was also shown that presence of the pores alone had a desired hampering 
effect on bacterial colonization. In the second approach, an antimicrobial peptide (AMP), 
RRPRPRPRPWWWW-NH2 (RRP9W4N), was used to covalently modify elastin like polypeptide 
(ELP) surface coatings having cell adhesive sequences in its structure. RRP9W4N was immobilized 
onto ELP surfaces using EDC-NHS coupling chemistry. It was shown that the AMP could retain its 
antibacterial activity against S. epidermidis, S. aureus and P. aeruginosa when covalently bonded to 
ELP. RRP9W4N stability in human blood serum was studied and the results suggested that the AMP 
could preserve its antibacterial activity up to 24 hours.  
The overall results from both surface modification techniques developed in this thesis suggest that they 
can be considered as promising candidates for the development of antimicrobial surfaces for future 
biomedical applications. 
 
Keywords: Antimicrobial surfaces, mesoporous titania, antibiotic delivery, antimicrobial peptide, 
elastin-like polypeptide 
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1.  Introduction 
 
 
Despite considerable progress in the development of biomaterials into the healthcare system, the 
attachment of pathogenic bacteria and subsequent biofilm formation is a significant limitation that 
undermines biomaterial’s clinical performance.1–3 Today, the post-operative antibiotic therapy is the 
most common treatment for biomaterial associated infection (BAI).  This is while over many years, such 
antibiotic therapy routines have not only been shown to fail in the treatment of  BAI, but has also resulted 
in a rapid increase in infections caused by bacteria having antiobiotic resistance.4–7 Moreover, the 
eradication of impenetrable and resistant biofilms with antibiotics increases the systemic side effects of 
antibiotics due to long term therapy sections and high dosage. That in turn can further accelerate the 
amount of antibacterial resistance and subsequent complications for patients.8–10 
Use of antibacterial surfaces to prevent initial bacterial colonization and biofilm formation is a practical 
strategy to fight BAI and to replace the need for conventional antibiotic therapies. Research on 
developing antibacterial surfaces is mainly focused on producing materials loaded with antibacterial 
agents, antibacterial immobilized surface coatings and surfaces with nanostructures.11 
The motivation behind my thesis is to design simple and applicable approaches to create antibacterial 
surfaces to prevent BAI. Today we live in an aging society with increased demand for use of 
biomaterials. However, very few of them have been designed to be effective against BAI. Moreover, 
antibiotic resistance is a growing global concern and according to World health organization in 2015, 
patients with infections caused by drug-resistant bacteria are generally at increased risk of worse clinical 
outcomes and death.  
In part 1 of the thesis, as demonstrated in Figure 1a, local antibiotic delivery from mesoporous titania 
thin films and the effect of nanoroughness of such thin films on bacteria adhesion were investigated and 
discussed (Paper 1). 
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Figure 1. Schematic demonstrating the objective of this thesis a, part 1: Antibiotic delivery from mesoporous 
titania coating and b, part 2: Antimicrobial modification of ELP surface coatings by covalent immobilization of 
RRP9W4N. 
The second part of this thesis, as illustrated in Figure 1b, is focused on the use of antimicrobial peptides 
(AMPs) as antibacterial agents. More specifically, RRP9W4N was covalently attached onto a bioactive 
surface coating made by recombinant elastin like peptide (ELP) and its effect on the biofilm formation 
was investigated (Paper 2). Due to low propensity of bacteria to develop resistance to AMPs, they are 
believed to be promising candidates to replace antibiotics.  
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1.1. Biomaterial associated infection (BAI) 
 
1.1.2. Biofilm formation  
 
When biomaterials are inserted into the body, they create a local defect in the immune system and 
provide a favorable surface for bacterial colonization. Planktonic bacteria are often present around the 
wound area, or in the blood circulation, and when they attach to the surface of biomaterials, they start 
to expand and produce a slime of extracellular polymeric substance (ECM). Inside this matrix the 
population of bacteria grows into a mature 3D structure called a biofilm.12–14 
A biofilm consists of a hetererogenous population of cells that, despite the same genotype, can vary 
significantly in phenotype. These include so called persister cells that can enter a dormant state, 
rendering them unsusceptible to conventional antibiotics.15 Like many types of chronic infections, the 
infection associated with biomaterials is generally caused by the formation of biofilms as the biofilm 
protects the microorganisms from the host’s defense and antibiotic therapy. As a consequence, treatment 
of an infection after formation of a biofilm is almost inpossible without removing the infected implant 
followed by long-term antibiotic therapy and revision surgery, which is a painful and expensive 
procedure.16–19  
 
 
   Figure 2. Schematic of biofilm development on a solid surface occurring in four steps. 
 
         1.1.3. BAI common pathogens 
 
Most common pathogens responsible for BAI include Gram-positive Staphylococcus aureus and 
Staphylococcus epidermidis, Gram-negative Escherichia coli and Pseudomonas aeruginosa and those 
from the Proteus group.20,21 S. aureus and P. aeruginosa infections usually proceed rapidly and are 
generally more aggressive than BAI caused by S. epidermidis. However, S. epidermidis being part of 
the normal human skin flora, is an opportunistic pathogen with high accessibility to the surgical sites.22 
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1.2. Antibacterial surface coatings 
 
A variety of modification techniques for fabrication of antibacterial surfaces have been developed. 
Functionalization of bioactive surface coatings is a commonly used approach to create antibacterial 
surfaces with good cell integration ability. Such surfaces are required to fulfil their function, withstand 
the complex biological environment and keep their antibacterial properties. Generally, such coatings 
function as 1) coatings that prevent bacterial adhesion (effect of surface energy and/or roughness), 2) 
bactericidal coatings, which kill the adherent bacteria (physical killing), 3) coatings that accelerate the 
adherence of adjacent tissue cells (cell adhesive sequences), 4) coatings that are loaded with or 
immobilized by antibacterial agents and 5) coatings that combine two or more of the functions.23–25  
 
          1.2.1. Antibiotic surface modification 
 
Applying surface coatings that release antibiotics from biomaterials is considered as an effective strategy 
to prevent BAI.  Such coatings are loaded with antibiotics and administrate these at the site of 
implantation and can kill the pathogens before a biofilm has the possibility to form.26 This approach 
results in transfer of antibiotics with higher local concentration and decreased systemic side effects 
compared to the conventional systemic antibiotic therapy via injection or oral routes. However, most of 
the time, the release kinetics are difficult to control and the drug level will either exceed or remain below 
the minimal inhibitory concentration.27,28 Moreover, the duration of the drug release must be restricted 
to a limited period of time to prevent antibacterial resistance caused by antibiotic therapy. To address 
these issues, an alternative approach is to covalently bond antibiotics to surfaces.28 So far a number of 
common clinical antibiotics, such as penicillin and Vancomycin have been chemically immobilized on 
biomaterial surfaces. This approach seems to have the advantage of long-lasting antimicrobial activity, 
lower side effects and non-accumulation in other tissues.29–32  
 
1.3.  Mesoporous titania thin films 
 
Mesoporous materials have suitable properties such as tunable textural properties, high surface area and 
pore volume to be applied for drug-delivery purposes.33–36 The use of mesoporous materials, such as 
titania that is being used in this thesis, has been highlighted in previous studies to improve 
osseointegration using local delivery of osteoporosis drugs.37 Moreover, such materials have the 
advantage of combining nanoroughness to create low bacterial adhesive materials with the ability of 
administrating antimicrobial agents. For example, in previous studies sustained release of cephalothin 
and amoxicillin from mesoporous titania-coated implants in vitro have been reported.38,39  
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1.4. Antimicrobial peptides (AMPs) 
 
Increased rate of resistance in human pathogens narrows down the available antibacterial therapeutic 
options to treat infections. As a consequence, there is a need for an alternative with broad spectrum of 
activity and minimized potency to develop resistance. Therefore, alternative drugs such as antimicrobial 
peptides (AMPs) are receiving increased attention.40–43 Antimicrobial peptides are part of the innate 
immune system and acts as a first response towards invading pathogens.43,44 Cationic AMPs are short 
peptides consisting of less than 50 amino acids with a positive net charge of +2 to +9.  
The main mode of AMPs mechanism of action involves interactions with the bacterium membrane 
leading to its rupturing and breakdown of the bacteria (Figure 3). Due to this, pathogens have less 
propensity to develop resistance to AMPs compared to traditional antibiotics.45  
 
Figure 3. Simplified schematic of antimicrobial peptide mechanism of action through damaging the bacteria cell 
membrane and succeeding pore formation.  
 
Target specificity is one important consideration in using AMPs. Bacterial membranes mainly consist 
of anionic phospholipids and are deficient in cholesterol, while human cells consists of zwitterionic 
phospholipids and are enriched in cholesterol. This makes bacterial membranes negatively charged and 
more prone to be invaded by positively charged molecules such as AMPs.46  
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1.5. Elastin like polypeptides (ELP) 
 
Elastin is a naturally occurring extracellular matrix protein that can predominantly be found in 
connective tissues.47  
Elastin like poly peptides (ELP) are engineered peptides that are synthesized by translating a desired 
sequence of amino acids encoded into a plasmid by living organisms. ELP can be readily expressed and 
purified in E-coli culture, which simplifies its large scale purification, Figure 4a.48 Its structure is 
composed of a repeating pentapeptide sequence Val–Pro–Gly–Xaa–Gly, where the guest residue (Xaa) 
can be any naturally occurring amino acid except proline.49 The protein engineering approach in ELP 
production, enables a precise control over the properties of the resulting protein. Moreover, it makes it 
possible to incorporate specific individual amino acids into the peptide sequence to confer chemical 
modifications. Cell- adhesive RGD domains can be included into the ELP to improve the bioactivity 
and cell attachment properties, Figure 4b.50 ELP has recently been considered as a promising material 
for biomedical applications. It has lately been shown that coatings made of ELP with RGD sequences 
are favorable for cell interactions, enhance osseointegration and subsequent bone formation.51  
 
 
 
 
 
 
Figure 4. a, Schematic of steps in expression and purification of ELP from E-Coli culture. b, Proposed ELP 
structure modified with bioactive RGD sequences. 
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2. Experimental 
 
 
The experiments performed and discussed in this work are presented in two sections; the first part is 
focused on the antibacterial performance of mesoporous titania thin films and the experiments include; 
1) synthesis of mesoporous titania thin films with different pore sizes, 2) antibiotic loading/release from 
mesoporous titania surfaces, 3) the effect of antibiotic release, surface nanoroughness and 
hydrophobicity on bacterial attachment (Paper 1). The second part of the experimental includes 
antimicrobial peptide immobilization on ELP substrates and the experiments are focused on 1) 
expression and purification of elastin like polypeptides (ELP), 2) ELP substrate preparation 3) AMP 
immobilization onto ELP surfaces and the effect on bacteria (Paper 2). 
 
Part I   
2.1. Antibacterial performance of mesoporous titania thin films 
 
2.1.1. Mesoporous titania thin film preparation 
 
Cubic mesoporous titania with pore sizes of 4, 6, and 7 nm were formed by the evaporation-induced 
self-assembly method (Figure 5). Pluronic® P123 (triblock copolymer EO20PO70EO20) and 
cetyltrimethylammonium bromide (CTAB) (CH3(CH2)15N(CH3)3Br), were used as structure directing 
agents . Larger pores (7 nm) were formed utilizing an organic additive, polypropylene glycol (PPG, Mn 
~4,000), which was used as a swelling agent. A titania precursor solution was prepared by adding 2.1 g 
titanium (IV) ethoxide (20%) to 1.6 g concentrated hydrochloric acid (37%) under vigorous stirring, 
forming a homogenous solution. The amphiphile (0.5 g) was separately dissolved in 8.5 g ethanol under 
vigorous stirring followed by mixing with the precursor solution. The final solution was left to stir 
overnight to achieve a homogenous mixture. To obtain uniform thin films of mesoporous titania, 100 
μL of the final solution was spin-coated (7,000 rpm) for 1 minute on glass slides (2×2 cm), titanium 
discs (8 mm diameter and 3mm thickness) and Ti-coated QCM-D sensors using a Spin150 spin coater. 
The coated substrates underwent aging for 1 day at room temperature to obtain complete self-assembly. 
When the swelling agent was used, a moderately humid environment (RH=54%) was provided by a 
saturated KNO3 aqueous solution in a refrigerator (T=4°C±1°C) during the aging process. Finally, the 
films were calcined by heating with a heating ramp of 1°C/min to 350°C, at which temperature they 
were left for 4 hours to remove the template and to cross-link the titania. Nonporous titania thin films 
were formed as control samples using the same procedure, but without the addition of amphiphiles. 
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Figure 5. Schematic of the formation procedure to form cubic mesoporous titania thin films using the evaporation 
induced self-assembly method. 
 
2.1.2. Hydrophobic surface modification 
Mesoporous titania thin films were treated in 5% dichlorodimethylsilane (DCDMS) for 1 hour. This 
step was used to hydrophobically modify the substrates and lower their surface energy. A schematic of 
surface silanization process is demonstrated in Figure 6. To ensure a sufficient amount of silanol groups 
on the titania surface, the substrates were pre-treated in water baths at  25°C for 45 minutes, then placed 
in a DCDMS solution for 15 minutes and thereafter flushed with chloroform to wash off the unreacted 
silanol groups from the surface, followed by another 45 minutes treatment in DCDMS. The modified 
films were dried using nitrogen gas.  
 
Figure 6. Schematic of silanization of mesoporous titania using DCDMS. 
 
2.1.3. Antibiotic release from mesoporous titania  
 
Substrate immersion was used to load mesopororus titania with antibiotics. The surfaces were immersed 
in antibiotic solutions for 1 hour. Vancomycin and gentamicin were dissolved in water (1 wt%) and 
Daptomycin was dissolved in methanol (1 wt%). DCDMS-treated mesoporous thin films were used to 
load Daptomycin, and the non-modified surfaces were used for Gentamicin and Vancomycin.
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2.1.4. Bacteria culture and growth 
 
S. aureus (ATCC 25923) and P. aeruginosa (ATCC 35984) were used to study the bacterial attachment 
and growth on the mesoporous titania with different pore sizes both with and without incorporated 
antibiotics. One day prior to the experiments, centrifuge tubes of 5 mL tryptic soy broth ( 30 g/L, Sigma) 
were inoculated by a single isolated colony from cultured agar plates of each bacterium. The inoculated 
cells were cultured in a shaking incubator at 200 rpm for 18 hours at 37°C until they reached stationary 
phase. The optical density of the bacterial suspension was adjusted to 0.52 at 620 nm (estimated to give 
109 colonies) using a plate reader (Spectramax M3 Multimode Microplate Reader; Molecular Devices 
LLC, Sunnyvale, CA, USA). 
Each bacterial solution was diluted at a ratio of 1:100 using simulated body fluid supplemented with 1% 
fetal bovine serum (FBS), and the mesoporous titania samples were seeded with 1 mL of the diluted 
solution. The samples with bacteria were then cultured for 1 hour in an incubator (ambient air) at 37°C 
to promote the attachment of the bacteria onto the titania surfaces. After 1 hour of culturing, media 
containing the unattached planktonic bacteria was aspirated. The samples were rinsed once with PBS 
and fresh media (simulated body fluid +1% FBS) was placed onto each sample. Samples were cultured 
for another 47 hours and at the end of this time period, they were rinsed three times with PBS. Each 
sample was placed inside a sterile 15 mL centrifuge tube filled with 2 mL of PBS. Samples were 
vortexed at 3,000 rpm for 2 minutes to release adherent bacteria into the PBS solution. Afterward, each 
bacterial solution was diluted twice, 1:10, and then each dilution was plated as five 10 µL spots onto 
sterile tryptic soy broth agar plates. Agar plates were placed inside an incubator at 37°C and 5% CO2 
for colonies to grow. The colonies on each plate were counted and the total number of colonies per 
milliliter of vortexed solution was calculated and converted to colony- forming units/mL. 
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Part II 
 
2.2.  Antimicrobial peptide immobilization onto elastin-like polypeptide thin films 
 
2.2.1.  Expression and purification of ELP 
 
ELP containing RGD sequences was expressed recombinantly in Escherichia host. A plasmid encoding 
the elastin like and RGD sequences was transformed into the E-Coli host and isopropyl 𝛽-D-1 
thiogalactopyranocide (Sigma) as T7-lac promoter was added to induce the expression. After culturing, 
the bacteria were lysed and the protein was purified using repetitive centrifuge cycles at above and below 
the lower critical solution temperature of the ELP (4°C and 37°C). The purified ELP was dialyzed, 
freeze dried and stored at 4°C. 
 
2.2.2. ELP thin film preparation 
 
A photo reactive heterobifunctional N-hydroxysuccidimide ester-diazirine crosslinker (NHS-diazirine, 
succinimidyl 4,4’-azipentanoate, Pierce Biotechnology) was dissolved in DMSO (2 mg/mL) and mixed 
with a solution of ELP in PBS (2 mg/mL). The reaction was incubated for 2 hours and 1M tris buffer 
was added to the solution to stop the reaction. The diazirine conjugated ELP was dialyzed against DI 
water, frozen and lypholized. All ELP coated surfaces mentioned subsequently, refers to this photo 
crosslinkable form of ELP modified with diazirine. Microscope glass coverslips (VWR, 15 mm) were 
cleaned using basic piranha. The polished titanium discs (grade 4, 8 mm in diameter and 3 mm in 
thickness) were rinsed with 70% ethanol followed by sonication. All substrates were dried with N2 gas 
and stored at 4°C before ELP deposition. A 50 mg/mL (5wt. %) solution of ELP in PBS was prepared 
at 4°C. The deposition of ELP onto the substrates was perfromed by spin coating. For the glass 
substrates, 50 l of the ELP solution and for the Ti discs 30mL of the ELP solution was applied to the 
center of the surface and spun at 4000 rpm for 90 seconds. The spin coated substrates were treated by 
UV-light using a 365 nm, 8 W light source for 1 hour for ELP crosslinking. The crosslinked films were 
rinsed 3 times for 0.5 hour with PBS prior to the experiments to remove any non-crosslinked ELP.  
 
2.2.3. AMP immobilization on ELP surfaces 
 
A solution of antimicrobial peptide RRPRPRPRPWWWW-NH2 (RRP9W4N, Red Glead Discovery 
AB, Lund, Sweden) was prepared in sterilized water to a concentration of 200 μM.  For covalent 
attachment of AMP to the ELP surfaces, the ELP coated substrates were submerged into a solution of 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-Hydroxysuccinimide 
(NHS) in MES buffer (PH=6) at a final concentration of 2mg/mL and were allowed to react for 30 
minutes slowly shaken at room temperature.
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Surfaces were then washed 3 times in PBS (pH 7.4) and suspended in the AMP solution for 2 hours in 
room temperature. The surfaces were then washed 3 times for 0.5 hour to remove the unreacted peptides 
from ELP surfaces and used for bacterial assays. The same procedure was used to prepare surfaces on 
Ti QCM-D discs (QSX 310, Q-sense) for QCM-D anaylsis and Ti discs for SEM analysis. 
 
2.2.4. Bacteria culture 
 
S. epidermidis (ATCC 35984), S.  aureus (CCUG 56489) and P. aeruginosa (CCUG 10778) were used 
to assess biofilm formation on the surfaces. One day before the experiment a sterilized 10 µL loop was 
used to withdraw a single colony from cultured agar plates of each bacterium to inoculate a tube of 5mL 
tryptic soy broth (TSB). The inoculated cells were cultured in an incubator for 6h, diluted in TSB and 
cultured in the incubator overnight to reach the stationary phase for bacterial growth.  
The optical density of the bacteria culture was adjusted to 0.7 at 620 nm (estimated to give 109 colonies) 
using a spectrometer. The bacterial suspension was centrifuged for 10 minutes at 2500 rmp and the 
formed bacteria pellet was suspended in the fresh TSB media. 2 mL of the suspension was seeded onto 
the glass substrates, ELP coated substrates, activated ELP substrates and AMP functionalized ELP 
substrates in a 12 well plate. Bacteria were then cultured for 24 hours and 48 hours under standard 
culture condition (ambient air at 37°C) to promote biofilm formation onto the surfaces. For the 48 hours 
time point, after 24 hours of culture, the media was aspirated and replaced with fresh TSB for another 
24 hours culture. At the end of each time point, surfaces were rinsed 3 times with fresh PBS to wash off 
any unattached planktonic bacteria before biofilm analysis.  
 
2.2.5. Evaluation of AMP immobilization on ELP substrates 
 
2.2.5.1. Monitoring by QCM-D 
 
The uptake and grade of attachment of AMP on EDC/NHS activated surfaces were studied by QCM-D 
(Q-sense E4, Sweden). Two titanium QCM-D discs (QSX 310, Q-sense) were coated with ELP and one 
of the surfaces activated with EDC/NHS, as described earlier.  Pure titanium discs and none-activated 
titanium discs were used as controls for this test. Milli-Q H2O was used as the solvent (AMP solution) 
and rinsing liquid. The mass of adsorbed AMP (ng/cm2) was calculated from the shifts in the frequency 
using the Sauerbrey equation (Eq. 1).   
 
(𝐸𝑞. 1)                                       ∆𝑚 = −
∆𝑓 × 𝐶
𝑛
 
, where ∆m is the adsorbed mass, ∆f the frequency difference, C is the mass sensitivity constant (17.7 
ng.Hz-1cm-2) and n the overtone number. 
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2.2.5.2. Stability in serum using a fluorescent tagged AMP 
 
Fluorescent tagged AMP (5(6) carboxyfluorescein-RRPRPRPRPWWWW-NH2) was used to study the 
stability of AMP attachment and its distribution on surfaces after various duration of time. The tests 
were performed by incubating the fluorescent AMP functionalized surfaces in 20% human plasma serum 
(from 1 hour up to 3 weeks) and imaged using fluorescent microscopy. Bacterial assays were conducted 
to investigate for how long AMPs could keep their bactericidal functionality against S. epidermidis.  
 
 
 
2.3. Analytical techniques 
 
2.3.1. Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) 
 
In scanning electron microscopy (SEM), a beam of focused electrons are scanned over a solid sample 
to give high resolved images. The highest resolved images are obtained by detecting the signal from the 
secondary electrons that originates from the surface. In transmission electron microscopy (TEM), an 
accelerated high energy beam of electrons passes through ultra-thin samples and creates a high 
resolution image revealing the microstructural information. In part I of the thesis, SEM and TEM were 
extensively used for imaging the mesoporous titania thin films and powders. In part II of the thesis, SEM 
was used to image ELP thin films and morphology of the bacteria in biofilms formed on surfaces. All 
samples in the second part were gold sputtered at a rate of 3nm/min for 1 minute prior to SEM imaging.  
  
2.3.2. Small angle X-ray scattering 
 
Long-ranged structural order within materials can be revealed by means of small-angle X-ray scattering 
(SAXS). The scattered X-ray patterns reveal data about long-range periodicity and mesoscopic 
dimensions of the samples. In this work, mesoporus titania was grinded into a powder for SAXS 
measurements. The measurements were performed at MAX-lab, beam station I911 (Lund, Sweden) 
using synchroton radiation (𝜆= 0.91  Å) and a two dimensional Mar 165 CCD detector. 
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2.3.3.  X-ray diffraction  
 
X-ray diffraction is a method to determine the crystalline structure of a sample. When the sample is 
exposed to an X-ray beam, the atomic planes in the crystallites diffract the beam at certain angles with 
constructive interference of X-ray to fulfil the Bragg condition (Eq. 2). 
 
(Eq. 2)                          n𝜆 = 2dsin𝜃 
 
, where d is the lattice spacing, 𝜃 is the angle and 𝜆 is the wavelength of the incident beam. In part 1 of 
the thesis, the crystallinity of the mesoporous titania powders were evaluated by XRD. The X-ray 
diffractometer used was a Bruker D8 advance (Bruker Corporation, Billerica, MA, USA) with a 
radiation wavelength of 1.5405Å (Cu Kα1 radiation). 
 
 
2.3.4.  Quartz crystal microbalance with dissipation monitoring 
 
Quartz crystal microbalance with dissipation monitoring (QCM-D) is a mass sensitive analytical 
technique. Upon appliance of an AC voltage, a thin quartz crystal attached to a pair of gold electrodes, 
starts to oscillate at its acoustic resonance frequency. The mass uptake or release at the sensor surface 
causes changes in the resonance frequency (Δf) as a function of time. Δf can be converted to the mass 
adsorbed or desorbed (Δm) by applying the Sauerbrey equation (Eq. 1). 
Moreover, an energy dependent property of the surface, the dissipation (ΔD) can be measured by QCM-
D. ΔD is correlated to the viscoelastic properties of the adsorbed layer. 
In part I of the thesis, QCM-D was used to measure the absorbed mass of the drugs within the 
mesoporous titania thin films. In addition, the accessible pore volume was calculated from the amount 
of deuterium oxide (D2O) that was absorbed. In part II, the adsorption and attachment of antimicrobial 
peptides onto ELP surfaces before and after EDC/NHS activation were monitored by QCM-D and 
compared to pure Ti surfaces. The swelling ability of the ELP thin films was also measured by D2O 
adsorption tests. The instrument used was a Q-sense E4 and all samples were evalauted using titanium 
QCM-D discs (QSX 310, Q-sense).
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2.3.5.  X-ray photoelectron spectroscopy  
 
X-ray photon spectroscopy (XPS) also known as electron spectroscopy for chemical analysis (ESCA) 
is a surface sensitive analysis technique to determine the chemical composition of a surface. Low energy 
X-rays irradiate the samples and the binding energy of the photoelectrons leaving the sample allows for 
quantitative determination of the present surface elements. In part I of the thesis, XPS was used to 
examine the surface composition of mesoporous titania thin films before and after modification and drug 
loading. In part II, XPS was used to evaluate the ELP thin films before and after surface activation with 
EDC and NHS. The equipment used was a Quantum 2000 scanning microscope (Physical Electronics, 
Inc., Chanhassen, MN, USA) with a 100µm point diameter at a 5nm analysis depth. 
 
2.3.6.  Atomic force microscopy 
 
Atomic force microscopy (AFM) is a scanning probe microscopy method to measure local properties of 
a surface such as its roughness through interactive forces. In this thesis, AFM was used to measure the 
surface topography of the mesoporous titania films. The measurements were performed in semi-contact 
or intermittent mode at two different scan sizes (1 and 0.5 µm). A conical tip with a length of 200 nm 
and a radius of 5nm attached to an NT-RTESPA cantilever was used to scan the samples. The AFM 
used was an NT-MDT model (Moscow, Russia). 
 
2.3.7.  Fluorescence light microscopy 
 
Fluorescence light microcopy (FLM), is used to image samples that are either fluorescently labeled or 
fluorescing in their natural form (autofluorescence). When fluorescent samples are irradiated with 
absorbable light of a specific wavelength, they can emit energy detectable as visible light. In this 
technique, the microscope filters out only the desired wavelength that matches the fluorescing sample. 
As a result, the electrons in the fluorescing specimen are excited to a higher energy level and when they 
relax, emit visible light. The emitted light reaches a second barrier filter to eliminate the residual 
background light from the specimen to pass to the eye or camera. Thus, the fluorescing sample shine 
out against a dark background with high contrast. FLM was extensively used in part II of this thesis to 
study the live and dead fractions of biofilms formed on ELP substrates with and without AMP 
functionalization. The microscope used was a Carl Zeiss GmbH (Jena –Germany) equipped with a HBO 
100 microscope illuminating system. Green filter, GFP, 38HE (𝜆Excitation = 470 nm and 𝜆Emission=525 nm) 
and red filter , 43 DS Red ( 𝜆Excitation = 545 nm and 𝜆Emission=605 nm) were used for imaging. The biofilm 
were stained using LIVE/DEAD®BacLight™ Bacterial Viability Kit (Molecular probes, Invitrogen). 
The images were obtained with SYTO® 9 and propidium iodide nucleic acid staining provided in the 
kit. Live bacteria with intact cell membranes appeared green and dead bacteria with compromised 
membranes appeared red. The statistical data from live/dead bacteria obtained from red and green 
fractions of fluorescent microscopy images were presented by the mean value with standard deviation. 
All the experiments were performed three times with two replicates. 20 images from each surface were 
used to obtain the image analysis data.  FML was also used to image fluorescent tagged antimicrobial 
peptides to study their stability in serum condition.
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3.  Results and discussion 
 
The results presented and discussed in this thesis are divided into two parts. In the first part, the 
formation and evaluation of mesoporous titania thin films, antibiotic delivery and the bacteria response 
to mesoporous titania surfaces are presented (Paper 1). In the second part, the antimicrobial peptide 
immobilization onto elastin like poly peptides and bacterial assays are presented (Paper 2).  
3.1. Part I 
3.1.1. Mesoporous titania thin film evaluation 
 
According to the SEM micrographs, evenly distributed porous titania were formed on titanium substrates 
(Figure 7). The thicknesses of the films, as obtained by cross-section analysis, was ~200 nm for the ones 
formed using P123 and CTAB and  ~700 nm when the swelling agent PPG was added to P123. The 
addition of PPG increased the viscosity, which probably resulting in a thicker film upon spin coating. 
The average pore size of each film was calculated directly from the SEM and TEM micrographs (Figure 
7) and are presented in Table 1. It was shown that mesoporous titania thin films with pore diameters of 
4, 6, and 7 nm, accessible on the surface, were successfully formed. The obtained pore diameters 
correlate well with the size of the templates used in the syntheses. 
 
Figure 7. a, SEM micrographs of mesporous titania thin films formed using different templates; from left to right  
CTAB, P123 and P123+PPG (1:1). b, SEM images of the cross-section of mesoporous titania coatings, P123, 
CTAB and P123+PPG (1:1) from top to bottom. c, TEM images of mesoporous titania thin films scraped off from 
the substrates P123, CTAB and P123+PPG (1:1) from left to right. d, A graph showing the pore sizes obtained 
from the TEM micrographs.  
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The pore volume of the titania films was calculated from the QCM-D data obtained from H2O/D2O 
exchange experiments using the mass difference between water and heavy water, Table 2. As expected, 
the volume increased with increasing pore size and increased film thickness. 
Table 1. Properties of mesoporous titania thin films including average pore diameter obtained from SEM images, 
the percentage of pore coverage on the surface calculated from SEM images and the pore volume of the 
mesoporous titania thin films accessible for water obtained from QCM-D measurements.  
 
Template Average 
pore 
diameter 
(nm) 
Pore surface 
coverage 
(±5%) 
Pore 
volume 
(%) 
 
CTAB 4 18 75 
P123 6 25 57 
P123 + 
PPG (1:1) 
7 42 55 
 
 
Clear Bragg peaks appeared in SAXS diffractograms for the mesoporous samples. The peaks appeared 
at different positions with various intensities while for the nonporous sample no peaks were observed, 
Figure 8b. The peaks were relatively broad indicating that the degree of order was relatively low, which 
is probably a result of the spin-coating technique used. Films formed by dip coating instead of spin 
coating usually show higher degree of order while the films formed by spin coating are more 
homogenous in thickness.52  
XRD results showed the formation of crystalline anatase TiO2. (Mincryst#191). The crystalline structure 
was the same for all the formed films including the nonporous. In figure 8a, a representative 
diffractogram for the titania films is shown. 
 
Figure 8. a, A representative XRD pattern obtained from mesoporous titania powders. b, SAXS diffractograms of 
mesoporous titania powders, see the graph legend for the sample names.  
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Results from XPS (Table 2) showed that the surface chemistry was similar on all the formed mesoporous 
titania films, including the nonporous, and consisted of carbon, oxygen, and titanium, no other impurities 
were detected. The surface roughness was measured using AFM, Table 3. The only significant 
difference in surface roughness was observed between the porous and nonporous surfaces; however, all 
the surfaces were still considered to be smooth on a micrometer length scale.  
 
Table 2. The chemical composition given in atomic percentage (%) of the mesoporous titania thin films measured 
with XPS. 
Template C1s O1s Ti2p 
P123+PPG 26.85 53.88 19.03 
CTAB 24.79 55.32 19.16 
P123 20.7 57.43 21.88 
 
 
Table 3. Average roughness (Ra) obtained by AFM from mesoporous titania surfaces using two different scan 
sizes. 
 
Average roughness (Ra) by AFM(nm) 
Pore size (nm) Scan size 0.5 * 0.5 m Scan size 1 *1 m 
7 10.35 14.80 
6 19.74 24.74 
4 10.17 12.87 
nonporous 0.96 1.85 
 
Static contact-angle measurements were performed before and after surface modification with DCDMS. 
According to Table 4, it shows that the surface energy drastically decreased upon DCDMS 
functionalisation, forming a more hydrophobic substrate. 
 
Table 4. Results from static contact angle experiments before and after DCDMS modification 
Surface Contact Angle 
(°) on pure 
titania 
Contact Angle 
(°) after DCDMS 
treatment 
4 nm <5 85 
6 nm <5 80 
7 nm <5 110 
nonporous 7 100 
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From the combined material characterization results it is clearly seen that the physical and chemical 
properties of the mesoporous titania thin films remain the same independently on pore size, which 
provide it possible to investigate the effect of pore size alone on drug loading and antibacterial responses. 
 
3.1.2. Drug release from mesoporous titania thin films 
 
The drug loading and release behavior from mesoporous titania thin films were directly correlated to the 
pore size and volume of the pores as measured by H2O absorption. (Paper 1) 
High loading and fast release rates were observed for the antibiotics according to QCM-D 
measurements, as is shown in Figure 9. 
 
 
Figure 9. QCM-D recordings obtained from loading and release of the three different antibiotics: a) Gentamicin, 
b) Vancomycin, and c) Daptomycin on mesoporous titania with variable pore sizes (For Daptomycin DCDMS 
modified surfaces were used).  
* Indicates start of rinsing with solvent to follow the release. 
 
It should be noted that all drug-release studies were monitored upon constant rinsing with the solvent, 
water or methanol, at a rate of 50 mL/min. This rate is considered to give rise to a much higher release 
compared to the biological situation. Therefore, the results from the release kinetics cannot be directly 
transferred to the clinical situation.  
The dissipation did not change noticeably during loading of the drugs, indicating that no viscoelastic 
film was formed onto the mesoporous titania. 
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3.1.3. Bacterial response 
 
Results from bacterial assays showed that mesoporous titania thin films, apart from their function as 
hosts for antibiotics, can to some extent hinder bacterial growth. These results indicate that the presence 
of pores alone can affect the adhesion of bacteria S. aureus and P. aeruginosa onto surfaces, Figure 10a.  
 
 
 
Figure 10. a, Data from counting the colony forming units grown on modified and unmodified mesoporous titania  
a, without the presence of antibiotics. b, with and without Gentamicin c, with and without Vancomycin d, with 
and without Daptomycin. Values are mean ±SD, N=3, *p<0.05 compared to mesoporous titania surfaces for each 
bacteria strain. MPT = mesoporous titania. 
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According to the results obtained from counting the colony forming units, the least adhesion of bacteria 
was observed on the hydrophobic mesoporous titania with 4 nm pore sizes indicating that the bacterial 
attachment was lower when the surface energy of the substrate decreased, Figure 10a. However, it is not 
clear whether it is the surface energy and nanotopography of the substrates that control the bacteria 
adhesion directly or the fact that changing these parameters can affect the adsorption of the fetal bovine 
serum proteins present in the media, which consequently affect the bacteria attachment onto surfaces. 
A predictable pattern was observed when the surfaces were loaded with antibiotics, Figure 10b,c,d. As 
expected, by increasing the size of the pores and loading higher amounts of antibiotics, the attachment 
of bacteria on the surfaces was decreased. This result confirms that mesoporous titania films can be 
considered as efficient drug release coatings on implants to fight bacterial adhesion and consequent 
biofilm formation. Furthemore, it is possible to regulate the amount of antibiotic loading by changing 
the pore size and film-thickness.  
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3.2. Part II 
 
The results discussed in this part, are focused on the antimicrobial peptide immobilization onto ELP thin 
films and the bacteria response to these surfaces (Paper 2). 
 
3.2.1.  ELP thin film evaluation 
 
Photo-crosslinked ELP with cell adhesive RGD sequences was fabricated into thin films as a substrate 
for immobilization of antimicrobial peptides. ELP coatings have previously been shown to have 
sufficient mechanical strenght to endure clinically relevant shear forces.50  Moreover, it has been shown 
that such coatings are favorable for cell interactions, enhance osseointegration and bone formation in 
vivo.51 The crosslinking is performed by conjugation of diarizine molecule to the ELP, which was 
activated by UV-exposure after spin coating. A reactive carbene intermediate is generated upon UV-
exposure to covalently bond to the titanium surface (Figure 11a). SEM images of dried ELP coatings 
demonstrate a uniform coating on the micro scale with porous structure in the nano scale (Figure 11b). 
The morphology of the crosslinked films were not changed after extensive washing in physiological 
conditions (PBS, 37°C) indicating a stable ELP coating. 
 
 
Figure 11: a, Proposed schematic model for conjugation of ELP onto Ti substrates using diarizine moiety. b, SEM 
of photocrosslinked ELP onto Ti substrate, the magnification increases from left to right. 
 
 
 
 CHAPTER THREE, Results and discussion part II  
23 
 
 
QCM-D experiments with H2O/ D2O exchange were performed to measure the swelling ability of ELP 
thin films in water, Figure 12. The density difference between the H2O and D2O was used to calculate 
the amount of absorbed water. It was shown that the ELP thin films swelled ͠   17 times in water.  
 
Figure 12. QCM-D recordings showing the amount of D2O when exchanged with Milli-Q water absorbed onto 
ELP thin films. A pure Ti surface was used as control. 
 
3.2.2. Antimicrobial peptide immobilization 
 
Immobilization of antimicrobial peptides onto surfaces is suggested to be an effective approach to 
minimize their cytotoxicity and increase their long-term stability for clinical applications.28,53–55  
The AMP, RRPRPRPRPWWWW-NH2, which was used to modify the ELP substrates is a cationic 
peptide rich in proline and arginine amino acids modified with hydrophobic Tryptophan (W) residues. 
The RP side chain provides a positive charge to facilitate bonding to negatively charged phospholipid 
head groups of bacteria membranes. The presence of W limits the toxicity of the AMP to eukaryotic 
cells since the formed amphipathic structure allows this peptide to only penetrate deep into the 
interfacial region of negatively charged membranes.56–59 EDC/NHS coupling chemistry was used to 
covalently attach the antimicrobial peptide onto ELP surfaces. In this method, EDC activates abundant 
hydroxyl groups on ELP for direct reaction with primary amine groups present in the AMP structure.  
NHS is used together with EDC to improve the efficiency and create dry-stable (amine-reactive) 
intermediates. A schematic of AMP immobilization onto ELP coating via EDC-NHS coupling is 
shown in Figure 13. According to XPS results, activating surfaces with EDC and NHS did not add any 
impurites to ELP coatings before and after AMP attachment, see Table 5. 
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Figure 13. Schematic model for EDC/NHS activation and AMP attachment on ELP coated on Ti surfaces. 
 
Table 5. The atomic percentage (%) of the chemical composition of ELP thin films coated on Ti discs before and 
after AMP conjugation by EDC/NHS coupling, as measured by XPS. 
 C1s N1s O1s Ti2P 
Titanium disk 0.75 0.29 55.80 43.16 
ELP coated Ti 64.20 15.71 20.09 - 
ELP Coated Ti + AMP 51.98 16.88 31.14  
 
QCM-D measurements were performed to investigate the attachment stability of covalently bonded 
antimicrobial peptide into ELP surfaces and to compare it with when it is physically adsorbed onto the 
ELP thin films. It was shown that a higher content of antimicrobial peptide was attached to the 
EDC/NHS activated ELP surfaces compared to non-activated surfaces, Figure 14. The same behavior 
was observed on the activated and non-activated Ti surfaces. However, the AMP amount bound to ELP 
surfaces after EDC/NHS activation is significantly higher. Upon rinsing with Milli-Q water, most of the 
AMP remained on the activated surface while the whole content of AMPs was released from the other 
surfaces. These results confirm a stable attachment of AMP onto ELP surfaces via the EDC/NHS 
coupling approach. 
 
Figure 14. QCM-D results obtained from loading and washing AMP onto ELP surfaces with and without EDC-
NHS activation. Pure Ti surfaces were used as control. 
 CHAPTER THREE, Results and discussion part II  
25 
 
 
According to the results from the bacteria studies, RRPRPRPRPWWWW-NH2 immobilized onto ELP 
thin films resulted in antimicrobial coatings. In Figure 15, the results from fluorescent imaging of 
biofilms with live/dead staining clearly demonstrate a high bactericidal effect on the surfaces modified 
with AMP. The statistical data obtained from calculating the green and red fractions using the ImageJ 
software from fluorescent microscopy images demonstrates a significant increase in the amount of dead 
bacteria on the AMP-functionalized surfaces (Figure 16). Additionally, the total area of the biofilm 
formed on these surfaces are clearly smaller than those without AMP. 
 
 
Figure 15. Images of biofilms formed onto ELP thin films with and without AMP. The bacteria are stained with 
SYTO® 9 and propidium iodide. The live bacteria appear green and the dead bacteria appear red. a, S. epidermidis 
b, S. aureus and c, P. aeruginosa. 
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Figure 16. Data from analyzing the live and dead fractions of biofilms formed on ELP surfaces with and without 
AMP. The values are obtained from analyzing fluorescent images. Values are mean ±SD, N=3. 
 
 
From the SEM images shown in Figure 17, clear distorstions in bacterial shape can be seen if they have 
been subjected to AMP modified surfaces. These results suggest that the AMP physically affects the 
bacterial membrane causing them to deform.  
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Figure 17. SEM images of bacteria taken after 24h a, S. epidermidis b, S. aureus and c, P. aeruginosa. The 
magnification increases from left to right. The pictures on the top row are the biofilms formed on ELP surfaces 
and the bottom row shows the bacteria grown on AMP functionalized ELP surfaces. 
 
The overall results implies that the interaction of AMP with the bacteria outer membranes causes a lethal 
activity.  
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3.2.3. AMP stability 
 
Few studies have been performed investigating the long-term stability of antimicrobial peptides in their 
intended clinical environment. One major challenge in the development of peptide based 
pharmaceuticals towards the clinic are their inherent instability towards enzymatic degradation in 
vivo.60,61  
In this section of the thesis, results from experiments investigating the stability of immobilized AMP on 
ELP using fluorescent microscopy and bacterial assays are presented and discussed. We have taken the 
approach to investigate the in vitro stability of peptides in serum, since this has been shown to be a 
representative model for their in vivo stability.60  
 
 
3.2.3.1. Fluorescent AMP in serum  
 
In Figure 18, microscopy images showing the fluorescently labeled AMP modified ELP in both human 
blood serum and water as a function of time is presented. As can be seen, the immobilized peptides had 
started to aggregate after 24 hours when treated in serum, while in water no difference could be observed 
up to 3 weeks. The bacterial assay on AMP functionalized surfaces at the same duration of time showed 
that the immobilized antimicrobial peptides started to loose its activity after 24 hours in serum and that 
the antimicrobial activity was totally lost after 48 hours, Figure 19.  
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Figure 18. Fluorescent microscopy images of 5(6) carboxyfluorescein tagged RRPRPRPRPWWWW-NH2  
immobilized onto ELP surfaces treated in 20% human blood serum at different duration of time. Milli-Q water 
treated peptides was used as control.  
(S= 20% serum media, W= Milli-Q water media)            
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Figure 19. Bacteria (S. epidermidis) response to AMP functionalized surfaces treated in 20% serum at different 
duration of time. 
 
These results suggest that the stability of AMP has been enhanced by the immobilization onto ELP 
surfaces compared to what has been reported when they are dissolved in serum media. Most evaluated 
AMPs show a half-life time stability of a only a few minutes to a few hours under physiological salt and 
serum conditions.62–64 The reasons for why AMP becomess ineffective in serum is suggested to be 
caused by an increased ionic strength and the presence of serum proteins, which can lead to change in 
the peptide conformation and loss of activity due to peptide degredation. 
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4.  Conclusion 
 
The vulnerability to develop infection after surgery is a significant limitation that undermines  
biomaterial’s performance in clinical applications. Creating antimicrobial biomaterials by means of 
modifying the surface is a promising solution to avoid such biomaterials associated infections.  
In this thesis, two approaches to create surfaces that hinder bacterial colonization and growth are 
presented. One approach is based on the use of mesoporous titania (MPT) with the ability to release 
antibiotics. Mesoporous titania thin films with pore sizes of 4, 6 and 7 were formed and successfully 
loaded with three different antibiotics; Vancomycin, Gentamicin and Daptomycin. The antiobiotic 
loaded MPT films showed a significant reduction in the attachment of S. aureus and P. aureginosa.  It 
was also shown that a smaller pore size and decreased surface energy of the MPT alone had a desired 
effect in reducing bacterial attachment without the use of antibiotics.  
The other approach examined in the thesis was to create a bactericidal surface with the use of 
antimicrobial peptides. An antimicrobial peptide (AMP), RRPRPRPRPWWWW-NH2, was covalently 
bonded to recombinant elastin protein (ELP) substrates and the bacterial response was evaluated. 
Engineered ELP having RGD sequences and photo-reactive sites were expressed in E-Coli culture 
followed by purification. Uniform ELP thin films were formed by spin coating, followed by crosslinking 
using UV radiation. NHS/EDC coupling chemistry was used to covalently bond the AMP to ELP. S. 
aureus, S. epidermidis and P. aeruginosa were used to evaluate the functionality and results showed a 
significant bactericidal effect when the films were functionalized with AMP. The stability of the AMP 
was studied in serum media and it was shown that the antimicrobial effect lasted up to 24 hours in the 
presence of human blood serum. 
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